 |
Jordan pharma group mulls injectables unit saleJordan-based Hikma Pharmaceuticals said it is reviewing options for its lucrative injectables business after receiving several unsolicited expressions of interest, driving up its shares nearly 8 per cent to a life-high. The inject More… |
 |
Hikma’s H1 revenue hits $523m, up 35pcUK-based Hikma Pharmaceuticals, a fast growing global pharmaceutical group, has posted revenue of $532.3 million for the first half of the year, marking a 34.8 per cent increase over the same period last year. The group, with sales in m More… |
 |
Hikma in anti-cancer tie-up with German firmHikma Pharmaceuticals has partnered with Germany-based drug development firm Ergomed in an agreement that see Ergomed manage clinical trials for one of Hikma’s key anti-cancer products in Jordanian hospitals. In turn, Hikma will provide Er More… |
